A novel mass spectrometry-based assay for GSK-3β activity

BMC Biochemistry

Volumn 6, Issue , 2005, Pages

  Bowley, Erin ^a   Mulvihill, Erin ^a   Howard, Jeffrey C ^a   Pak, Brian J ^b   Bing, Siang Gan ^a,c   O'Gorman, David B ^a,c  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b CIPHERGEN BIOSYSTEMS INC   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; PHOSPHATE; RECOMBINANT ENZYME; SYNTHETIC PEPTIDE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; PEPTIDE; PHOSPHORUS; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; FIBROBLAST; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; DRUG ANTAGONISM; ENZYME SPECIFICITY; KINETICS; METABOLISM; METHODOLOGY; PHOSPHORYLATION; SYNTHESIS;

ANIMALIA;

GLYCOGEN SYNTHASE KINASE 3; KINETICS; LITHIUM CHLORIDE; MASS SPECTROMETRY; PEPTIDES; PHOSPHORUS RADIOISOTOPES; PHOSPHORYLATION; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY;

EID: 31544439637     PISSN: 14712091     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-6-29     Document Type: Article

References (38)

1. Ahn NG, Resing KA: Toward the phosphoproteome. Nat Biotechnol 2001, 19(4):317-318.
2. Hunter T: Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 1995, 80(2):225-236.
3. Ermak G, Davies KJ: Calcium and oxidative stress: from cell signaling to cell death. Mol Immunol 2002, 38(10):713-721.
4. Embi N, Rylatt DB, Cohen P: Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. Eur J Biochem 1980, 107(2):519-527.
5. Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH: Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett 1992, 147(1):58-62.
6. Diehl JA, Cheng M, Roussel MF, Sherr CJ: Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998, 12(22):3499-3511.
7. Watcharasit P, Bijur GN, Song L, Zhu J, Chen X, Jope RS: Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53. J Biol Chem 2003, 278(49):48872-48879.
8. Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR: Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 2000, 14(19):2501-2514.
9. Kim L, Kimmel AR: GSK3, a master switch regulating cell-fate specification and tumorigenesis. Curr Opin Genet Dev 2000, 10(5):508-514.
10. Welsh GI, Proud CG: Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem J 1993, 294 (Pt 3):625-629.
11. Jope RS, Johnson GV: The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 2004, 29(2):95-102.
12. Phiel CJ, Klein PS: Molecular targets of lithium action. Annu Rev Pharmacol Toxicol 2001, 41:789-813.
13. Jope RS: Anti-bipolar therapy: mechanism of action of lithium. Mol Psychiatry 1999, 4(2):117-128.
14. Su Y, Ryder J, Li B, Wu X, Fox N, Solenberg P, Brune K, Paul S, Zhou Y, Liu F, Ni B: Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing. Biochemistry 2004, 43(22):6899-6908.
15. Kozlovsky N, Belmaker RH, Agam G: GSK-3 and the neurodevelopmental hypothesis of schizophrenia. Eur Neuropsychopharmacol 2002, 12(1):13-25.
16. Murphy E: Inhibit GSK-3beta or there's heartbreak dead ahead. J Clin Invest 2004, 113(11):1526-1528.
17. Tong H, Imahashi K, Steenbergen C, Murphy E: Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3- kinase - dependent pathway is cardioprotective. Circ Res 2002, 90(4):377-379.
18. Kaytor MD, Orr HT: The GSK3 beta signaling cascade and neurodegenerative disease. Curr Opin Neurobiol 2002, 12(3):275-278.
19. Grimes CA, Jope RS: The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 2001, 65(4):391-426.
20. Nikoulina SE, Ciaraldi TP, Mudaliar S, Mohideen P, Carter L, Henry RR: Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes 2000, 49(2):263-271.
21. Brabek J, Hanks SK: Assaying protein kinase activity. Methods Mol Biol 2004, 284:79-90.
22. Welsh GI, Patel JC, Proud CG: Peptide substrates suitable for assaying glycogen synthase kinase-3 in crude cell extracts. Anal Biochem 1997, 244(1):16-21.
23. Ryves WJ, Fryer L, Dale T, Harwood AJ: An assay for glycogen synthase kinase 3 (GSK-3) for use in crude cell extracts. Anal Biochem 1998, 264(1):124-127.
24. Doble BW, Woodgett JR: GSK-3: tricks of the trade for a multitasking kinase. J Cell Sci 2003, 116(Pt 7):1175-1186.
25. Cadieux PA, Beiko DT, Watterson JD, Burton JP, Howard JC, Knudsen BE, Gan BS, McCormick JK, Chambers AF, Denstedt JD, Reid G: Surface-enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS): a new proteomic urinary test for patients with urolithiasis. J Clin Lab Anal 2004, 18(3):170-175.
26. Aebersold R, Mann M: Mass spectrometry-based proteomics. Nature 2003, 422(6928):198-207.
27. Thulasiraman V, Wang Z, Katrekar A, Lomas L, Yip TT: Simultaneous monitoring of multiple kinase activities by SELDI-TOF mass spectrometry. Methods Mol Biol 2004, 264:205-214.
28. Tolson J, Bogumil R, Brunst E, Beck H, Elsner R, Humeny A, Kratzin H, Deeg M, Kuczyk M, Mueller GA, Mueller CA, Flad T: Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients. Lab Invest 2004, 84(7):845-856.
29. Rosty C, Christa L, Kuzdzal S, Baldwin WM, Zahurak ML, Carnot F, Chan DW, Canto M, Lillemoe KD, Cameron JL, Yeo CJ, Hruban RH, Goggins M: Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res 2002, 62(6):1868-1875.
30. Xiao Z, Adam BL, Cazares LH, Clements MA, Davis JW, Schellhammer PF, Dalmasso EA, Wright GLJ: Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. Cancer Res 2001, 61(16):6029-6033.
31. Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW: Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002, 48(8):1296-1304.
32. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA: Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359(9306):572-577.
33. Reinders J, Lewandrowski U, Moebius J, Wagner Y, Sickmann A: Challenges in mass spectrometry-based proteomics. Proteomics 2004, 4(12):3686-3703.
34. Salih E: Phosphoproteomics by mass spectrometry and classical protein chemistry approaches. Mass Spectrom Rev 2004.
35. Wang QM, Roach PJ, Fiol CJ: Use of a synthetic peptide as a selective substrate for glycogen synthase kinase 3. Anal Biochem 1994, 220(2):397-402.
36. Cohen P, Frame S: The renaissance of GSK3. Nat Rev Mol Cell Biol 2001, 2(10):769-776.
37. Mandelkow EM, Drewes G, Biernat J, Gustke N, Van Lint J, Vandenheede JR, Mandelkow E: Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett 1992, 314(3):315-321.
38. Kaidanovich O, Eldar-Finkelman H: The role of glycogen synthase kinase-3 in insulin resistance and Type 2 diabetes. Expert Opin Ther Targets 2002, 6(5):555-561.